Baseline plasma Cortisol levels and response to dexamethasone in a group of twenty five patienti with ma)or depressive disorder (Ml)D) and a control group of twenty five patients with psychiatric diagnoses other than MDD were estimated. The results of our study show that dexamethasone suppression test (DST) i« a useful diagnostic aid in MDD with melancholia with a sensitivity of 46% and specificity of 96%. Nonsuppression to DST is a marker of the state of melancholia and is not influenced by any other demographic or clinical variable. In our study 4 p.m. sample alone identified all the DST positive patients. MDD with melancholia showed significantly higher percentage of Cortisol hypersecretion and all non-suppressors were hypersecretory.
The function of adrenal cortex in depression is the most thoroughly studied aspect of clinical psychoendocrinology. Disturbance in the activity of Hypothalaniopituitary Adrenal (HPA) axis has been the subject ot extensive research. The importance ot the study of the UFA axis is due to the supposed relationship between life stress and depression and the clinical association between depression and diseases of the Pituitary -Adrenal system. It is now well accepted that in patients with depression the baseline plasma Cortisol level is elevated and also there is disturbance in the circadian rhythms of Cortisol secretion (Carroll et al 1976 , Schelesser et al 1980 . The abnormal escape from suppression with dexamethasone has been an area of particular interest. Carroll et al (1981) standardised the procedure for dexamethasone suppression test (DST). In their study DST identified patients with melancholia, a subtype of major depressive disorder (MDD) defined in DSM III (APA 1980) , with a sensitivity of 67% and a specificity of 96%. Non-supression was found to be a marker of the state of melancholia and was not influenced by other factors such as age, sex, frequency of episodes, duration of illness, severity of depression or psychotropic drugs, provided factors which can produce false negative and false positive results are eliminated. The diagnostic usefulness of DST in depression has been supported by the reports of Targum ct al (1982 ) Mcndlewicz et al (1982 Evans et al (1983) and Schat/bcrgct al (1983) . Hut several others workers Spar et al (1982) , Coppcn ct al (1983) , I lallstrom ct al (1983) and Bcrger et al (1984) questioned the diagnostic validity of DST by discussing several methodological problems in the earlier studies.
The present work is designed to study the HPA axis dysfunction, by measuring the baseline plasma Cortisol levels and studying the response to dexamethasone, in patients with MDD. The procedure was based on the procedure described by Carroll et al (1981) .
Material and Methods
25 patients (15 males and 10 females) who fulfilled the criteria in DSM III (APA 1980) for MDD were included in the experimental group. The control group consisted of 25 patients (14 males and 11 females) with psychiatric diagnosis other than MDD based on DSM III criteria.
Exclusion Criteria:
Organic brain syndromes and any major These patients were excluded because they have been known to give either false positive or false negative results in DST.
All the patients were evaluated in detail and data was collected regarding the age, sex, occupation, marital status, socioeconomic status, age of onset of the first episode, previous episodes and frequency, family history of psychotropic drug intake and presence of features of melancholia according to DSM III criteria. The severity of depression was rated on Hamilton's ratings scale for depression. No restriction was imposed on the diet and activity of patients. The test procedure was explained to the patients and their relatives and their consent was obtained.
After taking the blood sample at 11 p.m. on the first day, patient was given 1 mg. of dexamethasone orally. Further blood samples were collected at 4 p.m. and 11 p.m. on the second day. From the heparinised blood sample, plasma was separated and stored at -20° C and Cortisol level estimated in batches. Estimation of plasma Cortisol was done by radio-immunoassay technique. The assay was done using RIA kit supplied by Biodata Company, Italy. The estimation was done using Packard 5650 Automatic gamma counter. The psychiatrist who evaluated the patient was blind to the Cortisol levels and the biochemist was not aware of the clinical diagnosis till the entire data was collected. The value taken for non-suppression was plasma Cortisol level of £ 5 Mcg/dl.
Results
Analysis of demographic data showed no significant difference between the two groups regarding sex distribution, marital status and socioeconomic status. There was statistically significant difference in the mean age between the experimental and control groups (Mean Age in MDD Croup 40.59 ± 13,54; Control Group 25.64 ± 9.52; V < 0.001).
There was no significant difference in non-suppression when MD1) group as a whole was compared with the control group. But within the MDD group, only patients with melancholia showed nonsuppression and this was statistically significant in comparison with MDD without melancholia. The sensitivity of DST for diagnosis of melancholia in comparison with the control group was 46.15% and specificity was 96%. Non-suppression did not have any correlation with other factors like past history of affective illness, duration of present episode and unipolar or bioplar nature of the illness (Table 1 & 2) .
Non suppression was also not influenced by the severity of depression as measured on Hamilton's Rating Scale for depression. Eventhough there was statistically significant difference in mean age between the experimental and control groups, there was no difference between suppressors and non-suppressors in the age distribution (Table 3) .
Non suppression was observed in all the age groups (one patient in 21-30 years group; two patients in 31 to 40 years group; two patients in 51 to 60 years group and one in 61 to 70 years group) thereby showing that age was not the influencing factor.
There was no statistically significant difference between the MDD and control groups regarding pre-dexamethasone Cortisol level. But within the group of MDD significantly higher percentage of patients with melancholia were hypcrsecrctors (Table 4) . 
Discussion
Results of the present study indicate that non-suppression to DST is a state marker of melancholia and is not influenced by any of the demographic factors and other clinical variables. This finding is in agreement with the reports of other workers (Carroll et al 1981 , Mcndlewiez ct al 1982 , Schatzberg ct al 1983 , Targum ct al 1982 .
Eventhough there is some agreement regarding the diagnostic usefulness of DST in melancholia, the predictive value of the test varied in different studies. The variability has been attributed to diagnostic criteria used for sample selection, dose of dexamethasone administered, timing of the sample, method of estimation of plasma Cortisol and the criterion value taken for non-suppression. The influence of different methods of estimation on the results has been discussed by Maruta (1982) , Fang (1982) and Meltzer and Fang (1983) . Strokes et al (1984) argued that age and gender may affect the result and Berger et at (1984) discussed that stress of hospital admission and psychotropic drugs are some of the factors influencing non-suppression. The results of present study do not support the above possibility. Non-suppression was found both in outpatients and inpatients and also in patients on psychotropic drugs and those without.
It is widely discussed that weightloss is a significant factor influencing non-suppression. But Coppcn et al (1984) in their study of two groups -Depression with weight loss and depression without weight loss does not necessarily result in an abnormal DST result. They have shown non-suppression was seen in 73 % of depressive with weigh tloss and in 61 % of depressive without weight loss. Carroll et al (1981) suggested that two samples taken at 4 p. m and 11 p. m. increase the sensitivity of the test. In our study the 4 p. m. sample alone identified all the positive results. This indicates that DST can lie done with the 4 p. m. sample alone without loss of sensitivity or specificity. The importance oi this finding is regardingthe cost of the procedure and also in administration for outpatients.
In conclusion the results of our study show that DST is a laboratory test useful for the diagnosis of melancholia. Hut the results should be interpreted with caution considering the small sample size. Further research along with the other tests ot neuroendocrine battery may prove useful in identification of specific diagnostic tests for depressive illness.
It may be interesting to see the treatment responses in relation to DST and Brown et al (1980) have reported better response in a significantly higher percentage ot non-suppressors compared to suppressors. A project regarding treatment response is under current investigation by the authors.
